Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 12,500 shares at $49.84 ($615K) on 2020-10-06, disclosed to the SEC on 2020-10-07.
Open-market sale of $615k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.90 | 4,236 | $207K | 33.7% |
| 2 | $48.90 | 4,236 | $207K | 33.7% |
| 3 | $49.84 | 2,014 | $100K | 16.3% |
| 4 | $49.84 | 2,014 | $100K | 16.3% |
| Total | $49.20 avg | 12,500 | $615K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |